Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Previous Common Colds Could Boost Risks of More Severe COVID-19

September 29, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Having a common cold caused by seasonal coronaviruses may cause immune distraction, making some people’s immune systems respond less effectively to SARS-CoV-2 infection and increase their risk of more severe COVID-19.

NIH-Funded Study Shows Sound Sleep Supports Immune Function

September 21, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

Adults who cut back on sleep for six weeks had increased markers of inflammation.

Nationwide IRB Reliance Agreement Aimed at Speeding Research Reaches 1,000 Signatories

August 3, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program
  • Our Impact on Research Operations

The Streamlined, Multisite, Accelerated Resources for Trials (SMART) Institutional Review Board (IRB) agreement has reached 1,000 participating sites, making it one of the largest medical research study reliance agreements in the United States.

COVID-19 Hospitalization May Increase Heart Failure Risk

July 15, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program
  • National Clinical Cohort Collaborative (N3C)
  • Our Impact on Big Data

A large, retrospective study using National COVID Cohort Collaborative (N3C) data revealed that people who had been hospitalized with COVID-19 were more likely to develop heart failure during their recovery than people who had been hospitalized without COVID-19.

Study Finds Immune Dysfunction Is a Significant Risk Factor for COVID-19 Breakthrough Infection

June 3, 2022 - NCATS News

  • Clinical and Translational Science Awards (CTSA) Program

The National COVID Cohort Collaborative Data Enclave helps researchers identify a link between COVID-19 breakthrough infections and people with abnormal or impaired immune systems.

Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19

June 2, 2022 - NCATS News

  • COVID-19
  • Clinical and Translational Science Awards (CTSA) Program

A large NCATS-coordinated, randomized, placebo-controlled clinical trial showed that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — substantially improved clinical status and reduced deaths but did not significantly shorten time to recovery.

Last updated on July 9, 2026